drugset / Trial / NCT03371862

Liraglutide on Decreasing Parenteral Support in Short Bowel Patients (SLIPS)

NCT03371862

Phase 2 Withdrawn Imperial College London
NaSingle-groupOpen-labelTreatment

Summary

Pilot study looking at the effect on Liraglutide in the reduction of parenteral support in patients with short bowel.

Timeline

Start
2017-10-20
Primary completion
2020-08-06
Completion
2020-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Liraglutide Peptide

Indications